Warning! GuruFocus detected
1 Severe warning sign
with 6827.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
MegaPro Biomedical Co Ltd
ISIN : TW0006827009
Description
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.51 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 13.08 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.5 | |||||
| 3-Year EPS without NRI Growth Rate | -17.5 | |||||
| 3-Year FCF Growth Rate | -7.6 | |||||
| 3-Year Book Growth Rate | -23 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.8 | |||||
| 9-Day RSI | 38.18 | |||||
| 14-Day RSI | 37.2 | |||||
| 3-1 Month Momentum % | 2.29 | |||||
| 6-1 Month Momentum % | -23.21 | |||||
| 12-1 Month Momentum % | -44.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.41 | |||||
| Quick Ratio | 10.41 | |||||
| Cash Ratio | 5.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 | |||||
| Shareholder Yield % | -13.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1287092.86 | |||||
| Net Margin % | -1171721.43 | |||||
| FCF Margin % | -1038121.43 | |||||
| ROE % | -64.97 | |||||
| ROA % | -59.63 | |||||
| ROIC % | -141.07 | |||||
| 3-Year ROIIC % | 59.64 | |||||
| ROC (Joel Greenblatt) % | -182.1 | |||||
| ROCE % | -63.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.96 | |||||
| Price-to-Tangible-Book | 3.11 | |||||
| EV-to-EBIT | -3.2 | |||||
| EV-to-EBITDA | -3.58 | |||||
| EV-to-Revenue | 37411.85 | |||||
| EV-to-FCF | -3.58 | |||||
| Price-to-Net-Current-Asset-Value | 3.92 | |||||
| Price-to-Net-Cash | 8.91 | |||||
| Earnings Yield (Greenblatt) % | -31.26 | |||||
| FCF Yield % | -23.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
MegaPro Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.014 | ||
| EPS (TTM) (NT$) | -2.68 | ||
| Beta | -0.07 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.88 | ||
| Volatility % | 25.95 | ||
| 14-Day RSI | 37.2 | ||
| 14-Day ATR (NT$) | 0.699967 | ||
| 20-Day SMA (NT$) | 10.426 | ||
| 12-1 Month Momentum % | -44.97 | ||
| 52-Week Range (NT$) | 8.4 - 26.1 | ||
| Shares Outstanding (Mil) | 64.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MegaPro Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MegaPro Biomedical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
MegaPro Biomedical Co Ltd Frequently Asked Questions
What is MegaPro Biomedical Co Ltd(ROCO:6827)'s stock price today?
The current price of ROCO:6827 is NT$9.36. The 52 week high of ROCO:6827 is NT$26.10 and 52 week low is NT$8.40.
When is next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827)?
The next earnings date of MegaPro Biomedical Co Ltd(ROCO:6827) is .
Does MegaPro Biomedical Co Ltd(ROCO:6827) pay dividends? If so, how much?
MegaPro Biomedical Co Ltd(ROCO:6827) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers